{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:16:29Z","timestamp":1768486589914,"version":"3.49.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The transporters for norepinephrine and dopamine (NET and DAT, respectively) constitute the molecular targets for recreational drugs and therapeutics used in the treatment of psychiatric disorders. Despite a strikingly similar amino acid sequence and predicted topology between these transporters, some inhibitors display a high degree of selectivity between NET and DAT. Here, a systematic mutational analysis of non-conserved residues within the extracellular entry pathway and the high affinity binding site in NET and DAT was performed to examine their role for selective inhibitor recognition. Changing the six diverging residues in the central binding site of NET to the complementary residues in DAT transferred a DAT-like pharmacology to NET, showing that non-conserved binding site residues in NET are critical determinants for inhibitor selectivity. In contrast, changing the equivalent residues in the central site of DAT to the corresponding residues in NET had modest effects on the same inhibitors, suggesting that non-conserved binding site residues in DAT play a minor role for selective inhibitor recognition. Our data points towards distinct structural determinants governing inhibitor selectivity in NET and DAT and provide important new insight into the molecular basis for NET\/DAT selectivity of therapeutic and recreational drugs.<\/jats:p>","DOI":"10.1038\/srep15650","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T10:16:32Z","timestamp":1445940992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter"],"prefix":"10.1038","volume":"5","author":[{"given":"Jacob","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer B.","family":"Ringsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny","family":"Bang-Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Str\u00f8mgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders S.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"BFsrep15650_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.108.000869","volume":"63","author":"AS Kristensen","year":"2011","unstructured":"Kristensen, A. S. et al. SLC6 neurotransmitter transporters: structure, function and regulation. Pharmacol. Rev. 63, 585\u2013640 (2011).","journal-title":"Pharmacol. Rev."},{"key":"BFsrep15650_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","volume":"34","author":"AB Pramod","year":"2013","unstructured":"Pramod, A. B., Foster, J., Carvelli, L. & Henry, L. K. SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol. Aspects Med. 34, 197\u2013219 (2013).","journal-title":"Mol. Aspects Med."},{"key":"BFsrep15650_CR3","doi-asserted-by":"crossref","unstructured":"Andersen, J., Kristensen, A. S., Bang-Andersen, B. & Str\u00f8mgaard, K. Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters. Chem. Commun., 3677\u20133692 (2009).","DOI":"10.1039\/b903035m"},{"key":"BFsrep15650_CR4","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.1073\/pnas.0600905103","volume":"103","author":"R Chen","year":"2006","unstructured":"Chen, R. et al. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc. Natl. Acad. Sci. USA 103, 9333\u20139338 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep15650_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros, B., Jaber, M., Jones, S. R., Wightman, R. M. & Caron, M. G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606\u2013612 (1996).","journal-title":"Nature"},{"key":"BFsrep15650_CR6","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1021\/jm901189z","volume":"52","author":"FI Carroll","year":"2009","unstructured":"Carroll, F. I. et al. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction. J. Med. Chem. 52, 6768\u20136781 (2009).","journal-title":"J. Med. Chem."},{"key":"BFsrep15650_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/med.10014","volume":"22","author":"AH Newman","year":"2002","unstructured":"Newman, A. H. & Kulkarni, S. Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic. A focus on analogues of benztropine and rimcazole. Med. Res. Rev. 22, 429\u2013464 (2002).","journal-title":"Med. Res. Rev."},{"key":"BFsrep15650_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bcp.2007.08.007","volume":"75","author":"RB Rothman","year":"2008","unstructured":"Rothman, R. B., Baumann, M. H., Prisinzano, T. E. & Newman, A. H. Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction. Biochem. Pharmacol. 75, 2\u201316 (2008).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep15650_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1124\/jpet.111.191056","volume":"346","author":"KC Schmitt","year":"2013","unstructured":"Schmitt, K. C., Rothman, R. B. & Reith, M. E. Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators and partial substrates. J. Pharmacol. Exp. Ther. 346, 2\u201310 (2013).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep15650_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature10737","volume":"481","author":"H Krishnamurthy","year":"2012","unstructured":"Krishnamurthy, H. & Gouaux, E. X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature 481, 469\u2013474 (2012).","journal-title":"Nature"},{"key":"BFsrep15650_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nsmb.2894","volume":"21","author":"L Malinauskaite","year":"2014","unstructured":"Malinauskaite, L. et al. A mechanism for intracellular release of Na+ by neurotransmitter\/sodium symporters. Nat. Struct. Mol. Biol. 21, 1006\u20131012 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFsrep15650_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature03978","volume":"437","author":"A Yamashita","year":"2005","unstructured":"Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+\/Cl\u2212-dependent neurotransmitter transporters. Nature 437, 215\u2013223 (2005).","journal-title":"Nature"},{"key":"BFsrep15650_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature12533","volume":"503","author":"A Penmatsa","year":"2013","unstructured":"Penmatsa, A., Wang, K. H. & Gouaux, E. X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503, 85\u201390 (2013).","journal-title":"Nature"},{"key":"BFsrep15650_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nature06038","volume":"448","author":"SK Singh","year":"2007","unstructured":"Singh, S. K., Yamashita, A. & Gouaux, E. Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature 448, 952\u2013956 (2007).","journal-title":"Nature"},{"key":"BFsrep15650_CR15","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.1147614","volume":"317","author":"Z Zhou","year":"2007","unstructured":"Zhou, Z. et al. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 317, 1390\u20131393 (2007).","journal-title":"Science"},{"key":"BFsrep15650_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nsmb.1602","volume":"16","author":"Z Zhou","year":"2009","unstructured":"Zhou, Z. et al. Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures. Nat. Struct. Mol. Biol. 16, 652\u2013657 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFsrep15650_CR17","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nsmb.3029","volume":"22","author":"A Penmatsa","year":"2015","unstructured":"Penmatsa, A., Wang, K. H. & Gouaux, E. X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine. Nat. Struct. Mol. Biol. 22, 506\u2013508 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFsrep15650_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nature14431","volume":"521","author":"KH Wang","year":"2015","unstructured":"Wang, K. H., Penmatsa, A. & Gouaux, E. Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521, 322\u2013327 (2015).","journal-title":"Nature"},{"key":"BFsrep15650_CR19","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1074\/jbc.M505055200","volume":"281","author":"LK Henry","year":"2006","unstructured":"Henry, L. K. et al. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. J. Biol. Chem. 281, 2012\u20132023 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR20","doi-asserted-by":"publisher","first-page":"7782","DOI":"10.1073\/pnas.89.16.7782","volume":"89","author":"S Kitayama","year":"1992","unstructured":"Kitayama, S. et al. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl. Acad. Sci. USA 89, 7782\u20137785 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep15650_CR21","doi-asserted-by":"publisher","first-page":"43694","DOI":"10.1074\/jbc.M112.342212","volume":"287","author":"L S\u00f8rensen","year":"2012","unstructured":"S\u00f8rensen, L. et al. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket. J. Biol. Chem. 287, 43694\u201343707 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1124\/jpet.108.136200","volume":"325","author":"CC Walline","year":"2008","unstructured":"Walline, C. C., Nichols, D. E., Carroll, F. I. & Barker, E. L. Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognition. J. Pharmacol. Exp. Ther. 325, 791\u2013800 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep15650_CR23","doi-asserted-by":"publisher","first-page":"10276","DOI":"10.1074\/jbc.M806907200","volume":"284","author":"J Andersen","year":"2009","unstructured":"Andersen, J. et al. Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants. J. Biol. Chem. 284, 10276\u201310284 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR24","doi-asserted-by":"publisher","first-page":"29712","DOI":"10.1074\/jbc.M114.571521","volume":"289","author":"RA Dahal","year":"2014","unstructured":"Dahal, R. A. et al. Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site. J. Biol. Chem. 289, 29712\u201329727 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR25","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1124\/mol.107.043679","volume":"73","author":"ML Parnas","year":"2008","unstructured":"Parnas, M. L. et al. Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2\u03b2-carbomethoxy-3\u03b2-(4-chlorophenyl) tropane implicates proximity of cocaine and substrate active sites. Mol. Pharmacol. 73, 1141\u20131150 (2008).","journal-title":"Mol. Pharmacol."},{"key":"BFsrep15650_CR26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1523\/JNEUROSCI.19-02-00630.1999","volume":"19","author":"RA Vaughan","year":"1999","unstructured":"Vaughan, R. A., Agoston, G. E., Lever, J. R. & Newman, A. H. Differential binding of tropane-based photoaffinity ligands on the dopamine transporter. J. Neurosci. 19, 630\u2013636 (1999).","journal-title":"J. Neurosci."},{"key":"BFsrep15650_CR27","doi-asserted-by":"publisher","first-page":"8915","DOI":"10.1074\/jbc.M610633200","volume":"282","author":"RA Vaughan","year":"2007","unstructured":"Vaughan, R. A. et al. Localization of cocaine analog [125I]RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter. J. Biol. Chem. 282, 8915\u20138925 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR28","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1074\/jbc.M109.072587","volume":"285","author":"J Andersen","year":"2010","unstructured":"Andersen, J. et al. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter. J. Biol. Chem. 285, 2051\u20132063 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1124\/mol.113.091249","volume":"85","author":"J Andersen","year":"2014","unstructured":"Andersen, J. et al. Molecular basis for selective serotonin reuptake inhibition by the antidepressant agent fluoxetine (Prozac). Mol. Pharmacol. 85, 703\u2013714 (2014).","journal-title":"Mol. Pharmacol."},{"key":"BFsrep15650_CR30","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nn.2146","volume":"11","author":"T Beuming","year":"2008","unstructured":"Beuming, T. et al. The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat. Neurosci. 11, 780\u2013789 (2008).","journal-title":"Nat. Neurosci."},{"key":"BFsrep15650_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuropharm.2010.08.021","volume":"60","author":"H Bisgaard","year":"2011","unstructured":"Bisgaard, H. et al. The binding sites for benztropines and dopamine in the dopamine transporter overlap. Neuropharmacology 60, 182\u2013190 (2011).","journal-title":"Neuropharmacology"},{"key":"BFsrep15650_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1021\/ja906923j","volume":"132","author":"H Kolds\u00f8","year":"2010","unstructured":"Kolds\u00f8, H. et al. The two enantiomers of citalopram bind to the human serotonin transporter in reversed orientations. J. Am. Chem. Soc. 132, 1311\u20131322 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"BFsrep15650_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1124\/mol.113.088922","volume":"85","author":"K Severinsen","year":"2014","unstructured":"Severinsen, K. et al. Binding of mazindol and analogs to the human serotonin and dopamine transporters. Mol. Pharmacol. 85, 208\u2013217 (2014).","journal-title":"Mol. Pharmacol."},{"key":"BFsrep15650_CR34","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1074\/jbc.M109.045401","volume":"285","author":"S Sinning","year":"2010","unstructured":"Sinning, S. et al. Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter. J. Biol.Chem. 285, 8363\u20138374 (2010).","journal-title":"J. Biol.Chem."},{"key":"BFsrep15650_CR35","doi-asserted-by":"publisher","first-page":"39316","DOI":"10.1074\/jbc.M112.371765","volume":"287","author":"P Plenge","year":"2012","unstructured":"Plenge, P. et al. Steric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporter. J. Biol. Chem. 287, 39316\u201339326 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR36","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nsmb.1854","volume":"17","author":"DP Claxton","year":"2010","unstructured":"Claxton, D. P. et al. Ion\/substrate-dependent conformational dynamics of a bacterial homolog of neurotransmitter:sodium symporters. Nat. Struct. Mol. Biol. 17, 822\u2013829 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFsrep15650_CR37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nsmb.2816","volume":"21","author":"K Kazmier","year":"2014","unstructured":"Kazmier, K. et al. Conformational dynamics of ligand-dependent alternating access in LeuT. Nat. Struct. Mol. Biol. 21, 472\u2013479 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFsrep15650_CR38","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.1073\/pnas.1103060108","volume":"108","author":"J Andersen","year":"2011","unstructured":"Andersen, J. et al. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters. Proc. Natl. Acad. Sci. USA 108, 12137\u201312142 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep15650_CR39","doi-asserted-by":"publisher","first-page":"19459","DOI":"10.1074\/jbc.273.31.19459","volume":"273","author":"EL Barker","year":"1998","unstructured":"Barker, E. L. et al. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J. Biol. Chem. 273, 19459\u201319468 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR40","doi-asserted-by":"publisher","first-page":"15528","DOI":"10.1074\/jbc.M611705200","volume":"282","author":"JR Dodd","year":"2007","unstructured":"Dodd, J. R. & Christie, D. L. Selective amino acid substitutions convert the creatine transporter to a \u03b3-aminobutyric acid transporter. J. Biol. Chem. 282, 15528\u201315533 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR41","doi-asserted-by":"publisher","first-page":"36424","DOI":"10.1074\/jbc.M109.017509","volume":"284","author":"AR Edington","year":"2009","unstructured":"Edington, A. R. et al. Extracellular loops 2 and 4 of GLYT2 are required for N-arachidonylglycine inhibition of glycine transport. J. Biol. Chem. 284, 36424\u201336430 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR42","doi-asserted-by":"publisher","first-page":"8254","DOI":"10.1074\/jbc.M009798200","volume":"276","author":"C Roubert","year":"2001","unstructured":"Roubert, C. et al. Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity. J. Biol. Chem. 276, 8254\u20138260 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR43","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nrd2082","volume":"5","author":"RA Copeland","year":"2006","unstructured":"Copeland, R. A., Pompliano, D. L. & Meek, T. D. Drug-target residence time and its implications for lead optimization. Nat. Rev. Drug. Discov. 5, 730\u2013739 (2006).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"BFsrep15650_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/mol.115.099036","volume":"88","author":"PS Hasenhuetl","year":"2015","unstructured":"Hasenhuetl, P. S. et al. Ligand selectivity among the dopamine and serotonin transporters specified by the forward binding reaction. Mol. Pharmacol. 88, 12\u201318 (2015).","journal-title":"Mol. Pharmacol."},{"key":"BFsrep15650_CR45","doi-asserted-by":"publisher","first-page":"13118","DOI":"10.1073\/pnas.1104614108","volume":"108","author":"RO Dror","year":"2011","unstructured":"Dror, R. O. et al. Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc. Natl. Acad. Sci. USA 108, 13118\u201313123 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep15650_CR46","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature10867","volume":"482","author":"AC Kruse","year":"2012","unstructured":"Kruse, A. C. et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 482, 552\u2013556 (2012).","journal-title":"Nature"},{"key":"BFsrep15650_CR47","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/S0021-9258(17)37256-3","volume":"269","author":"H Gu","year":"1994","unstructured":"Gu, H., Wall, S. C. & Rudnick, G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics and ion dependence. J. Biol. Chem. 269, 7124\u20137130 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR48","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3565(24)38214-X","volume":"289","author":"AJ Eshleman","year":"1999","unstructured":"Eshleman, A. J. et al. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. J. Pharmacol. Exp. Ther. 289, 877\u2013885 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep15650_CR49","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","volume":"340","author":"M Tatsumi","year":"1997","unstructured":"Tatsumi, M., Groshan, K., Blakely, R. D. & Richelson, E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur. J. Pharmacol. 340, 249\u2013258 (1997).","journal-title":"Eur. J. Pharmacol."},{"key":"BFsrep15650_CR50","doi-asserted-by":"publisher","first-page":"12584","DOI":"10.1073\/pnas.91.26.12584","volume":"91","author":"KJ Buck","year":"1994","unstructured":"Buck, K. J. & Amara, S. G. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA 91, 12584\u201312588 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep15650_CR51","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0026-895X(25)10570-1","volume":"48","author":"KJ Buck","year":"1995","unstructured":"Buck, K. J. & Amara, S. G. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol. Pharmacol. 48, 1030\u20131037 (1995).","journal-title":"Mol. Pharmacol."},{"key":"BFsrep15650_CR52","doi-asserted-by":"crossref","first-page":"15985","DOI":"10.1016\/S0021-9258(17)33961-3","volume":"269","author":"B Giros","year":"1994","unstructured":"Giros, B. et al. Delineation of discrete domains for substrate, cocaine and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269, 15985\u201315988 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR53","doi-asserted-by":"publisher","first-page":"40324","DOI":"10.1074\/jbc.M213101200","volume":"278","author":"LJ Bryan-Lluka","year":"2003","unstructured":"Bryan-Lluka, L. J., B\u00f6nisch, H. & Lewis, R. J. \u03c7-Conopeptide MrIA partially overlaps desipramine and cocaine binding sites on the human norepinephrine transporter. J. Biol. Chem. 278, 40324\u201340329 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFsrep15650_CR54","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1073\/pnas.032386299","volume":"99","author":"CJ Loland","year":"2002","unstructured":"Loland, C. J., Norregaard, L., Litman, T. & Gether, U. Generation of an activating Zn2+switch in the dopamine transporter: mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle. Proc. Natl. Acad. Sci. USA 99, 1683\u20131688 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFsrep15650_CR55","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1471-4159.2008.05667.x","volume":"107","author":"KC Schmitt","year":"2008","unstructured":"Schmitt, K. C. et al. Interaction of cocaine-, benztropine- and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties. J. Neurochem. 107, 928\u2013940 (2008).","journal-title":"J. Neurochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep15650","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep15650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep15650.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:55:49Z","timestamp":1748667349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep15650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]}},"alternative-id":["BFsrep15650"],"URL":"https:\/\/doi.org\/10.1038\/srep15650","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]},"assertion":[{"value":"6 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.B.-A. is an employee of H. Lundbeck A\/S. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15650"}}